Delivery Order SPE2DB20D2104-SPE2DB25FNAWM
- Not listed
- The Defense Logistics Agency awarded a $25,899.93 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors, with an ultimate completion date of July 14, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery location is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $18,136.65 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injectors, with an ultimate completion date of August 22, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $12,962.95 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of SKYRIZI 150 mg/ml pen injections. This is a firm fixed-price contract with an ultimate completion date of July 28, 2025, and was competitively awarded with no set-aside designation. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999,999,999.00...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $20,588.83 for SKYRIZI 150 mg/mL pen injectors on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed-price contract, which received no set-aside designation, represents a competitive award to the major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency has awarded a delivery order valued at $40,155.43 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injectors, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside transaction executed on September 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with extensive experience...
- The Defense Logistics Agency awarded a $28,786.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors, with an ultimate completion date of July 15, 2025. This non-set-aside delivery order represents a competitive award to the pharmaceutical distributor, which is headquartered in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor...
- The Defense Logistics Agency awarded a $38,911.60 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of SKYRIZI 150 mg/ml pen injectors. This firm fixed price, non-set-aside contract will be completed by August 27, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $12,467 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of SKYRIZI 150 mg/ml pen injectors. This is a firm fixed-price delivery order with an ultimate completion date of October 21, 2025, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania facility. The award was made on a competitive basis with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency awarded a delivery order valued at $64,305.29 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/mL pen injectors. This firm fixed-price delivery order, awarded September 5, 2025, with completion targeted for September 8, 2025, will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete in open...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,142.34 for SKYRIZI 150 mg/mL pen injectors on August 4, 2025, with completion scheduled for August 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNAWMDelivery Order
The Defense Logistics Agency awarded a $127,949.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML pen injectors, with a completion date of September 19, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies an extensive portfolio of medications and medical supplies to support military and veteran healthcare systems. The SKYRIZI delivery represents part of the company's broader role under its DLA prime vendor contract, which encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to support the Defense Health Agency and other government healthcare systems globally. AmerisourceBergen's consistent track record of competitive award success demonstrates its capability to fulfill federal pharmaceutical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $127.9k | 9/18/25 |